Fed" State Glycogen Synthesis involves three main stages: Priming Requires energy input (specifically from ATP, to facilitate the conversion

Insulin and Glucagon work in opposition through phosphorylation and dephosphorylation of enzymes to regulate metabolic processes. (Phosphorylation is the addition of a phosphate group to a molecule, while dephosphorylation is the removal of a phosphate group.)

• Insulin stimulates dephosphorylation. (This process promotes anabolic reactions that help to synthesize energy storage macromolecules.)

• Glucagon stimulates phosphorylation. (Phosphorylation generally activates catabolic processes that provide energy by breaking down stored substrates.)

Glycogen Metabolism

• High Blood Glucose:

  • Insulin activates glycogen synthesis. (This leads to the conversion of glucose to glycogen for future energy needs.)

  • Blocks glycogen breakdown. (Prevents glucose from being released into the bloodstream, maintaining high blood glucose levels.)

• Low Blood Glucose:

  • Glucagon blocks glycogen synthesis. (This prevents further storage of glucose as glycogen.)

  • Activates glycogen breakdown. (This releases glucose into the bloodstream to elevate blood sugar levels.)

Hormonal Regulation in Skeletal Muscle

• Catecholamines (Adrenaline/Noradrenaline):

  • Stimulate phosphorylation of enzymes involved in glycogen metabolism. (This enhances the muscle's ability to utilize glucose for quick energy.)

Glycogen Metabolism:

• Block glycogen synthesis. (This redirects glucose for immediate use rather than storage.)

• Enhance glycogen breakdown. (This provides glucose rapidly through glycogenolysis.)

• Increase levels of fructose 2,6-bisphosphate, thus stimulating glycolysis. (This accelerates the conversion of glucose to pyruvate for energy.)

Genetic Deficiencies in Glycogen Metabolism

• Glycogen Storage Diseases:

  • Result from deficiencies in enzymes needed for glycogen degradation. (These are inherited metabolic disorders affecting the body's ability to process glycogen.)

  • Hepatic Forms:

  • Lead to fasting hypoglycemia and liver damage. (These conditions stem from uncontrolled glycogen accumulation and inadequate energy provision.)

  • Myopathic Forms:

  • Cause muscle weakness and wasting. (The body's muscle cells are unable to access glycogen stores effectively.)

• Specific Diseases:

  • Von Gierke Disease:

  • Caused by glucose-6-phosphatase deficiency. (This enzyme is crucial for converting glucose-6-phosphate into glucose.)

  • Impairs conversion of glucose-6-phosphate to glucose, leading to severe fasting hypoglycemia.

  • McArdle Disease:

  • Deficiency of glycogen phosphorylase in muscle tissue. (This is essential for breaking down glycogen into glucose within muscle cells.)

Fasting State and Glucose Maintenance

• After approx. 24 hours of fasting:

  • Liver glycogen stores are depleted. (Glycogen stores typically last for about 24 hours in fasting individuals.)

  • Body relies on gluconeogenesis to maintain blood glucose levels. (This metabolic pathway generates glucose from non-carbohydrate substrates.)

Gluconeogenesis and Glycolysis Functions

• Pathway Overlap:

  • Gluconeogenesis utilizes 7 of the 10 enzyme-catalyzed reactions from glycolysis. (This ensures that the two processes can efficiently share resources.)

  • Contains specific bypass reactions at three regulatory glycolysis points. (These bypasses are necessary to circumvent irreversible steps in glycolysis.)

  • Total ATP consumption in gluconeogenesis is 6 ATP. (This is higher energy expense compared to glycolysis, which produces ATP.)

Conversion of Glucose-6-Phosphate to Glucose

• Final Reaction:

  • Occurs during both gluconeogenesis and glycogen breakdown in the liver. (This step is critical for the ultimate release of glucose.)

  • Enzyme (Glucose-6-phosphatase) located in the ER membrane, enabling glucose secretion. (This localization is essential for the efficient release of glucose into the bloodstream.)

  • This enzyme is primarily expressed in the liver and kidneys. (These organs are vital for glucose homeostasis in the body.)

Von Gierke Disease (Type I Glycogen Storage Disease)

• Pathophysiology:

  • Caused by deficiency in glucose-6-phosphatase. (The lack of this enzyme disrupts normal glucose metabolism.)

  • Glucose-6-phosphate from both glycogen breakdown and gluconeogenesis cannot be converted to glucose.

  • Results in lack of glucose being released into the bloodstream, causing profound fasting hypoglycemia.

• Management:

  • Patients must have regular carbohydrate feeding and may require nocturnal gastric infusions of glucose or uncooked corn starch. (These measures help in sustaining blood glucose levels and preventing hypoglycemic events.)

Hormonal Regulation in the Liver: Glycolysis and Gluconeogenesis

• Fructose 2,6-bisphosphate:

  • Acts as a key regulator through which insulin and glucagon affect liver metabolism. (This molecule plays a crucial role in the balance between these two pathways.)

  • High cellular levels indicate:

  • Glycolysis is turned ‘on’.

  • Gluconeogenesis is turned ‘off’.

  • The levels are regulated by a bifunctional protein with two enzyme activities. (This protein facilitates reciprocal regulation of glucose metabolism pathways.)